NEETA VORST: Open Payments
NPI 1801399555 · SALEM, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,333 in 163 payments from 24 companies in 2025. Trend: 2023 $4,581 · 2024 $2,619 · 2025 $3,333
Food & beverage: $3,075Education: $258
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $578 |
| GENZYME CORPORATION | 20 | $426 |
| Regeneron Healthcare Solutions, Inc. | 23 | $355 |
| GlaxoSmithKline, LLC. | 23 | $325 |
| Mallinckrodt Hospital Products Inc. | 14 | $293 |
| ANI Pharmaceuticals, Inc. | 9 | $159 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $149 |
| Actelion Pharmaceuticals US, Inc. | 4 | $147 |
| United Therapeutics Corporation | 4 | $108 |
| La Jolla Pharmaceutical Company | 5 | $108 |
Products named: DUPIXENT, TEZSPIRE, ACTHAR, NUCALA, FASENRA, PURIFIED CORTROPHIN GEL, Tyvaso, GIAPREZA.
Industry payments across VA — which companies pay providers there.
